 |
|
|
| |
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, today announces it has opened a representative office in Shanghai, China, to further benefit from China's fast developing pharmaceutical manufacturing industry.
The new office, which is near to the centre of Shanghai, will be led by Joe Zou who has extensive experience of sourcing materials primarily for the pharmaceutical industry for supply into Europe. Joe previously worked for Whytes Chemicals in Shanghai for nearly 10 years. Joe's immediate focus will be supporting the newly aligned Aesica Technical Organisation headed by Chris Gowland, Aesica's Quality Director..
Aesica's newly aligned Technical Organisation, numbering over 50 heads in strength, provides a structure which allows the smooth progression from quote to chemistry or formulation development, through registration and into commercialisation. Along with a modern project management philosophy, this model will provide Aesica's customers in the contract manufacturing market with a fast, flexible, and professional offering.
Dr. Robert Hardy, CEO of Aesica said: "The Chinese pharmaceutical manufacturing industry has experienced rapid growth in recent years and has earned a reputation for delivering substantial cost benefits. By sourcing certain materials in China we can benefit from this and support our customers' lifecycle management by offering more cost effective starting materials, intermediates or final stage products. However, this is not simply about cost. Our overriding objective is to ensure that we continue to offer the best possible level of service to our customers with timely delivery of high quality and fully compliant products."
<< volver |
|
|
|
|
|
 |
|
 |
